UNSPSC 51101921: Chlorproguanil

This classification denotes an antiprotozoal agent with the molecular formula C11H15Cl2N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8O3249M729, chemically known as 1-(3,4-dichlorophenyl)-5-isopropylbiguanide but generally known as chlorproguanil, which bears US NIH Compound Identifier 9571037. European Medicines Agency schedules Chlorproguanil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06207MIG.

UNSPSC 51101921 Chlorproguanil, a Commodity code, shows limited direct activity in state and local procurement; the recent opportunities posted under this code do not center on chlorproguanil itself but rather on broader pharmaceutical, naloxone, and medical-supply procurements. The Seminole County, Florida IFB (IFB60459723LAS) solicits naloxone and drug deactivation systems for community health initiatives, while the City of Tampa's IFB (26P00145) covers a wide range of medical and first aid supplies for the Fire Department Rescue Division. The Texas Health and Human Services Commission's RFI (HHS0017013) addresses a Therapeutic Pharmacy Initiative focused on direct-to-manufacturer prescription fulfillment, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP (S1070000015802) seeks generic multi-source pharmaceuticals and OTC products through established wholesaler channels. The issuing bodies span county health departments, municipal fire departments, state health agencies, and regional cooperative purchasing entities—a mix typical of pharmacy and medical-supply procurement but not specific to chlorproguanil as a therapeutic agent.

Geographic activity appears concentrated in Florida, Texas, and Minnesota based on recent postings, with cooperative purchasing mechanisms (MMCAP) extending reach across multiple states including Oregon. The Seminole County solicitation requires quarterly deliveries to Sanford, Florida, with a response deadline of July 26, 2023; the Tampa Fire Department bid closed March 13, 2026, with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises; MMCAP's RFP closed March 26, 2026, with awards effective July 1, 2026; and the Texas HHS Commission's RFI closed April 3, 2026, as a preliminary market-intelligence phase before formal RFP issuance. The code shows little evidence of state and local procurement specifically targeting chlorproguanil as a discrete pharmaceutical product—the opportunities appear misclassified or tagged broadly within pharmaceutical categories rather than representing demand for this particular commodity.